Updated Jul 16, 2026
Thomasian Harry Jr. has filed 4 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $40K. Lifetime open-market sales: $1.30M.
Harry Jr. Thomasian serves as the Chief Financial Officer of Precigen, Inc., a biotechnology company focused on synthetic biology solutions. He has been involved in the company's financial operations, as indicated by his SEC filings.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | PGEN | PRECIGEN, INC. | S — Open-market sale | 171.4K | $5.53 | $948K |
| 2026-07-01 | PGEN | PRECIGEN, INC. | S — Open-market sale | 28.6K | $5.78 | $165K |
| 2026-06-01 | PGEN | PRECIGEN, INC. | S — Open-market sale | 41.9K | $4.36 | $183K |
| 2026-05-28 | PGEN | PRECIGEN, INC. | M — Option exercise | 87.5K | — | |
| 2026-03-20 | PGEN | PRECIGEN, INC. | M — Option exercise | 40.3K | — | |
| 2025-09-25 | PGEN | PRECIGEN, INC. | P — Open-market purchase | 2.9K | $3.42 | $10K |
| 2025-09-25 | PGEN | PRECIGEN, INC. | P — Open-market purchase | 8.3K | $3.62 | $30K |
Harry Jr. Thomasian serves as the Chief Financial Officer of Precigen, Inc., a biotechnology company focused on synthetic biology solutions. He has been involved in the company's financial operations, as indicated by his SEC filings.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($40K) and 3 open-market sales ($1.30M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Thomasian Harry Jr. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.